Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 2
1961 3
1962 2
1963 1
1965 3
1966 4
1967 2
1968 10
1969 2
1970 2
1971 7
1972 2
1973 2
1974 1
1975 1
1976 1
1977 2
1978 2
1979 2
1980 5
1981 6
1982 6
1983 2
1984 4
1985 5
1986 1
1987 3
1988 3
1989 3
1990 2
1991 1
1992 2
1993 1
1994 4
1995 1
1996 4
1997 4
1998 6
1999 7
2000 6
2001 5
2002 4
2003 6
2004 9
2005 15
2006 7
2007 13
2008 8
2009 19
2010 14
2011 14
2012 9
2013 7
2014 8
2015 15
2016 17
2017 15
2018 20
2019 10
2020 22
2021 23
2022 24
2023 25
2024 30
2025 29
2026 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

467 results

Results by year

Filters applied: . Clear all
Page 1
Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer.
Kotani D, Oki E, Nakamura Y, Yukami H, Mishima S, Bando H, Shirasu H, Yamazaki K, Watanabe J, Kotaka M, Hirata K, Akazawa N, Kataoka K, Sharma S, Aushev VN, Aleshin A, Misumi T, Taniguchi H, Takemasa I, Kato T, Mori M, Yoshino T. Kotani D, et al. Among authors: mishima s. Nat Med. 2023 Jan;29(1):127-134. doi: 10.1038/s41591-022-02115-4. Epub 2023 Jan 16. Nat Med. 2023. PMID: 36646802 Free PMC article.
ctDNA-based molecular residual disease and survival in resectable colorectal cancer.
Nakamura Y, Watanabe J, Akazawa N, Hirata K, Kataoka K, Yokota M, Kato K, Kotaka M, Kagawa Y, Yeh KH, Mishima S, Yukami H, Ando K, Miyo M, Misumi T, Yamazaki K, Ebi H, Okita K, Hamabe A, Sokuoka H, Kobayashi S, Laliotis G, Aushev VN, Sharma S, Jurdi A, Liu MC, Aleshin A, Rabinowitz M, Bando H, Taniguchi H, Takemasa I, Kato T, Kotani D, Mori M, Yoshino T, Oki E. Nakamura Y, et al. Among authors: mishima s. Nat Med. 2024 Nov;30(11):3272-3283. doi: 10.1038/s41591-024-03254-6. Epub 2024 Sep 16. Nat Med. 2024. PMID: 39284954 Free PMC article.
CIRCULATE-Japan: Circulating tumor DNA-guided adaptive platform trials to refine adjuvant therapy for colorectal cancer.
Taniguchi H, Nakamura Y, Kotani D, Yukami H, Mishima S, Sawada K, Shirasu H, Ebi H, Yamanaka T, Aleshin A, Billings PR, Rabinowitz M, Oki E, Takemasa I, Kato T, Mori M, Yoshino T. Taniguchi H, et al. Among authors: mishima s. Cancer Sci. 2021 Jul;112(7):2915-2920. doi: 10.1111/cas.14926. Epub 2021 Jun 7. Cancer Sci. 2021. PMID: 33931919 Free PMC article.
Barbed vs conventional sutures for cesarean uterine scar defects: a randomized clinical trial.
Maki J, Mitoma T, Ooba H, Nakato H, Mishima S, Tani K, Eto E, Yamamoto D, Yamamoto R, Kai K, Tamada T, Akamatsu K, Kawanishi K, Masuyama H. Maki J, et al. Among authors: mishima s. Am J Obstet Gynecol MFM. 2024 Sep;6(9):101431. doi: 10.1016/j.ajogmf.2024.101431. Epub 2024 Jul 16. Am J Obstet Gynecol MFM. 2024. PMID: 39019212 Free article. Clinical Trial.
Survival benefit of adjuvant chemotherapy based on molecular residual disease detection in resected colorectal liver metastases: subgroup analysis from CIRCULATE-Japan GALAXY.
Kataoka K, Mori K, Nakamura Y, Watanabe J, Akazawa N, Hirata K, Yokota M, Kato K, Kotaka M, Yamazaki K, Kagawa Y, Mishima S, Ando K, Miyo M, Yukami H, Laliotis G, Sharma S, Palsuledesai CC, Rabinowitz M, Jurdi A, Liu MC, Aleshin A, Kotani D, Bando H, Taniguchi H, Takemasa I, Kato T, Yoshino T, Oki E. Kataoka K, et al. Among authors: mishima s. Ann Oncol. 2024 Nov;35(11):1015-1025. doi: 10.1016/j.annonc.2024.08.2240. Epub 2024 Sep 16. Ann Oncol. 2024. PMID: 39293512 Free article.
HIBRID: histology-based risk-stratification with deep learning and ctDNA in colorectal cancer.
Loeffler CML, Bando H, Sainath S, Muti HS, Jiang X, van Treeck M, Reitsam NG, Carrero ZI, Meneghetti AR, Nishikawa T, Misumi T, Mishima S, Kotani D, Taniguchi H, Takemasa I, Kato T, Oki E, Tanwei Y, Durgesh W, Foersch S, Brenner H, Hoffmeister M, Nakamura Y, Yoshino T, Kather JN. Loeffler CML, et al. Among authors: mishima s. Nat Commun. 2025 Aug 14;16(1):7561. doi: 10.1038/s41467-025-62910-8. Nat Commun. 2025. PMID: 40813777 Free PMC article.
Clinical characterization of FGFR2b expression in patients with advanced gastric or gastroesophageal junction adenocarcinoma.
Sato S, Rhodes SL, Aoki Y, Nakayama I, Hashimoto T, Hawkins J, Yanes RE, Chang CH, Nakamura Y, Kawazoe A, Mishima S, Kotani D, Kuboki Y, Bando H, Kojima T, Yoshino S, Reading S, Honeycutt H, Finger E, Endo I, Sakamoto N, Kuwata T, Yoshino T, Shitara K. Sato S, et al. Among authors: mishima s. ESMO Open. 2025 Jul;10(7):105322. doi: 10.1016/j.esmoop.2025.105322. Epub 2025 Jun 12. ESMO Open. 2025. PMID: 40513139 Free PMC article.
467 results